• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: SIEMENS HEALTHCARE DIAGNOSTICS, INC. ADVIA CENTAUR XPT SARS-COV-2 IGG (COV2G); SARS-COV-2 IMMUNOASSAY

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

SIEMENS HEALTHCARE DIAGNOSTICS, INC. ADVIA CENTAUR XPT SARS-COV-2 IGG (COV2G); SARS-COV-2 IMMUNOASSAY Back to Search Results
Model Number N/A
Device Problem False Negative Result (1225)
Patient Problem No Clinical Signs, Symptoms or Conditions (4582)
Event Date 08/06/2021
Event Type  malfunction  
Manufacturer Narrative
The quality control (qc) results for both the cov2g and cov2t assays were within the range.No errors on the system when samples were run.The customer declined to have service checkout system.The advia centaur xpt cov2g ifu states in the limitations section: "a negative result for an individual subject indicates absence of detectable anti-sars-cov-2 antibodies.Negative results do not preclude sars-cov-2 infection and should not be used as the sole basis for patient management decisions.A negative result can occur if the quantity of the anti-sars-cov-2 antibodies present in the specimen is below the detection limits of the assay, or the antibodies that are detected are not present during the stage of disease in which a sample is collected.Results are not intended to be used as the sole basis for patient management decisions.Test results should be interpreted in conjunction with clinical observations, patient history, epidemiological information, and other laboratory findings." a false negative/non-reactive result would be correlated with clinical history and presentation and may lead to additional testing and/or continued precautions to avoid infection with negligible clinical impact.Although there is no potential for serious injury in this case, an mdr will be reported to the fda as a requirement of the emergency use authorization (eua).Siemens healthcare diagnostics is investigating.
 
Event Description
The customer obtained a nonreactive (negative) advia centaur xpt sars-cov-2 igg (cov2g) result for a patient sample that was considered discordant when compared to the reactive (positive) sars-cov-2 total (cov2t) result.The customer reported the result to the physician and the result was questioned.The patient had covid in (b)(6) 2020.There are no known reports of patient intervention or adverse health consequences due to the discordant cov2g result.
 
Manufacturer Narrative
Siemens filed the initial mdr 1219913-2021-00428 on august 25, 2021.September 16, 2021 additional information: siemens healthcare diagnostics investigated.The patient had covid in (b)(6) 2021.There is no pcr information available.The cov2g and cov2t may not always correlate.The cov2g method measures igg antibodies and the cov2t detects igg and igm antibodies.The total antibody is more sensitive than the igg method.A nonreactive test result does not exclude the possibility of exposure to or infection with sars-cov-2.Patient specimens may be nonreactive if collected during the early (pre seroconversion) phase of illness or due to a decline in titer over time.In addition, the immune response may be depressed in elderly, immunocompromised, or immunosuppressed patients.Results should always be interpreted in conjunction with the patient's medical history, clinical presentation and other findings.Based on the information provided siemens did not identify a product problem.No further evaluation of the device is required.In section h6, the investigation finding, and investigation conclusion codes were updated.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ADVIA CENTAUR XPT SARS-COV-2 IGG (COV2G)
Type of Device
SARS-COV-2 IMMUNOASSAY
Manufacturer (Section D)
SIEMENS HEALTHCARE DIAGNOSTICS, INC.
511 benedict avemue
tarrytown NY 10591 5097
MDR Report Key12364809
MDR Text Key268061186
Report Number1219913-2021-00428
Device Sequence Number1
Product Code QKO
Combination Product (y/n)N
PMA/PMN Number
EUA201697
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type health professional,user faci
Type of Report Initial,Followup
Report Date 09/23/2021
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received08/25/2021
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date10/04/2021
Device Model NumberN/A
Device Catalogue Number11206992
Device Lot Number007
Was Device Available for Evaluation? No
Date Manufacturer Received09/16/2021
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
-
-